Congo, Democratic Republic of the vs Niger: Access to anti-retroviral drugs, female
Congo, Democratic Republic of the
78.0%
in 2024
Niger
79.0%
in 2024
Congo, Democratic Republic of the rank
60th
Niger rank
59th
Access to anti-retroviral drugs, female over time
- Congo, Democratic Republic of the
- Niger
How they compare
Niger currently reports 79.0% against 78.0% in Congo, Democratic Republic of the, a difference of 1.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Niger ahead.
Congo, Democratic Republic of the ranks 60th and Niger ranks 59th of 141 countries.
Niger has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Congo, Democratic Republic of the | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.0% | 5.0% | 3.0% | Niger |
| 2010s | 25.7% | 54.5% | 28.8% | Niger |
| 2020s | 70.2% | 83.2% | 13.0% | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Congo, Democratic Republic of the or Niger?
- Niger, at 79.0% against 78.0% in Congo, Democratic Republic of the as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Congo, Democratic Republic of the and Niger?
- 1.0%, with Niger ahead.
- How many years of comparable data are there for Congo, Democratic Republic of the and Niger?
- 25 years are reported by both, from 2000 to 2024.
- How do Congo, Democratic Republic of the and Niger rank globally for access to anti-retroviral drugs, female?
- Congo, Democratic Republic of the ranks 60th and Niger ranks 59th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.